Background and Purpose-Carotid web (CW) is a rare form of focal fibromuscular dysplasia defined as an abnormal shelflike projection of intimal fibrous tissue into the carotid bulb. It is theorized that CW leads to ischemic stroke secondary to blood flow stasis and subsequent embolization. The natural history and optimal management of CW are unclear. To address this knowledge gap, we performed a systematic literature review (SLR) of CW. Methods-Our librarians performed a SLR for CW and related terminology. Patient-level demographics, stroke risk factors, neuroimaging findings, stroke recurrence or stroke free-duration, and treatment modality were extracted. We used descriptive statistics to characterize our results. When specific patient-level metrics were not reported, the denominators for reporting percentage calculations were adjusted accordingly. Results-Our literature search produced 1150 articles. Thirty-seven articles including 158 patients (median age 46 years [range 16-85], 68% women, 76% symptomatic) met entry criteria and were included in our SLR. Of the symptomatic CW patients: 57% did not have stroke risk factors, 56% who received medical therapy had recurrent stroke (median 12 months, range 0-97), and 72% were ultimately treated with carotid revascularization (50% carotid stenting, 50% carotid endarterectomy). There were no periprocedural complications or recurrent strokes in carotid revascularization patients. Conclusions-CW leads to ischemic stroke in younger patients without conventional stroke risk factors. We found a high stroke recurrence rate in medically managed symptomatic CW patients, whereas carotid revascularization effectively prevented recurrent stroke. Our findings should be interpreted with caution because of risk of publication and reporting bias.
C arotid web (CW), also known as atypical focal carotid bulb fibromuscular dysplasia (FMD), is a nonatherosclerotic disease of the extracranial carotid vasculature. First described in 1968 as a discrete ridge, 1 it is best defined radiographically as a distinctive, intraluminal filling defect commonly affecting the posterolateral wall of the carotid artery at the most proximal portion of the internal carotid artery. 2 Despite sharing a location typically associated with atherosclerotic disease, histologically, CW has been shown to represent a nonatherosclerotic entity. Surgical pathology of resected CWs demonstrates intimal fibrous proliferation without evidence of atheromatous deposits, consistent with a focal variant of intimal FMD. [3] [4] [5] This atypical, intimal pathology is in contrast to the classic, medial FMD often seen as a string of beads on imaging. CW has recently been recognized as a cause of stroke of undetermined cause, representing as many as 9.4% to 37% of cryptogenic strokes. 2, [6] [7] [8] However, published literature on CW remains sparse and the natural history and optimal management strategies are unclear. We undertook a comprehensive systematic literature review (SLR) of CW to synthesize the existing literature and better inform treatment of CW patients.
week 50, 2017) , and the Cochrane Library via Wiley. Controlled vocabulary and natural language searching were used, using terms such as CW, carotid shelf, intraluminal web, and carotid artery FMD. No limitations were placed on language, publication type, or publication date. The full search is listed in Appendix A. The search was conducted in English. The final literature search was conducted on December 15, 2017.
Data Abstraction
We obtained Institutional Review Board approval for our study, which included waiver of individual informed consent (STUDY00004374). In addition to the patients identified through SLR, we added 2 unpublished cases from our institution's prospective database. We manually extracted patient-level data for all reported CW patients, including demographics, conventional stroke risk factors, recurrent stroke, degree of stenosis, medical or surgical treatment strategies used, and whether the CW was symptomatic or asymptomatic. Conventional stroke risk factors were defined as hypertension, hyperlipidemia, atrial fibrillation, diabetes mellitus, smoking, migraine with aura, and oral contraceptive use. Degree of carotid stenosis was calculated using NASCET (The North American Symptomatic Carotid Endarterectomy Trial) methodology when imaging was available. Carotid stenosis was classified as mild (<50%), moderate (50%-70%), or severe (>70%). When the methodology for calculating degree of stenosis was unspecified and we were unable to retrospectively apply NASCET methodology, the reported degree of stenosis in the original article was used. Symptomatic CW was defined as anterior circulation stroke or transient ischemic attack ipsilateral to the CW.
Data abstraction was completed independently by 2 authors (A. J. Zhang and Dr Dhruv) and any discrepancies were resolved through review and consensus. Complete reporting of the variables of interest was not available for all patients. To improve our study's comprehensiveness, we contacted authors about the availability of missing data points. If an article included non-CW patients, only the subset of CW patients was included in our analysis. All available patient-level data were included. When variables were incompletely reported, the denominators for percentage calculations were adjusted accordingly. We reported our findings using descriptive statistics. We used Fisher exact test to compare rates of stroke recurrence between patients with mild, moderate, and severe carotid stenosis.
Results

Systematic Literature Review
Our search yielded 1150 total publications, 54 of which were duplicates. The abstracts of the remaining 1096 publications were screened with 88 publications reviewed in their entirety by 2 authors (A. J. Zhang and Dr Dhruv). Of these remaining 88 publications, 40 were considered relevant for our SLR. After contacting authors with multiple CW publications, an additional 3 articles were excluded because of overlapping patient cohorts. The 37 remaining publications were analyzed in the SLR (Figure 1 ). Of these 37 publications, 21 had 1 CW patient each. One German 9 and 2 Japanese 4,10 case reports, which were identified using the English language search, were included in the SLR.
A total of 160 patients with CW were included; 158 from the 37 publications identified in our SLR and 2 unique cases from our institutional database. One hundred thirty-five (84%) patients were symptomatic, 24 (15%) were asymptomatic, and 1 (1%) could not be classified (Table I in the online-only Data Supplement). The laterality of the CW lesion was reported in 120 patients, of which 26 (22%) patients had bilateral CW. We attempted to contact the authors of 22 published studies. We reached the authors of 10 studies, 3 of whom shared additional patient-level data.
Asymptomatic CW
Only a small number (n=50) of incidentally discovered asymptomatic CW were reported. Of these 50 asymptomatic CW, 26 patients had contralateral symptomatic CW and 24 patients had unilateral asymptomatic CW. The 24 patients with unilateral asymptomatic CW were 50% women with a median age of 52.5 years (range 16-78 years). Conventional stroke risk factors were uncommon (Table II in the online-only Data Supplement). Subsequent medical therapy was reported for 10 patients: 9 were treated with antiplatelet medications and 1 patient was anticoagulated. One patient was treated with carotid endarterectomy (CEA) because of recurring symptoms of lightheadedness. There were no reported cases of stroke or transient ischemic attack after incidental discovery of CW.
Demographics and Stroke Risk Factors of Patients With Symptomatic CW
The symptomatic CW patient population was relatively young (median age 46 years, range 29-85 years) with a higher prevalence of women (67%; Table 1 ). The majority of patients (70%) were of African race. The presence or absence of conventional stroke risk factors was reported in 94 patients, of whom only 40 (43%) had one or more risk factors. The most commonly reported stroke risk factors were oral contraceptive use (24%), hypertension (23%), smoking (17%), and hyperlipidemia (16%). Atrial fibrillation, diabetes mellitus, and migraine were uncommon (Table 1) .
Secondary Stroke Prevention
Of the 135 symptomatic CWs, 97 (72%) had defined secondary stroke prevention (Table 2) . Forty-seven patients with symptomatic CW were managed medically: 91% (n=43) received antiplatelet agents and 9% (n=4) anticoagulation (3 Coumadin, 1 unspecified anticoagulation). Of these 47 patients, follow-up data were available in 45. Twenty-five (56%) of the medical 
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December 2018 management patient cohort had stroke recurrence distal to the CW with a median time to recurrent stroke of 12 months (range 0-97 months). The stroke recurrence rate was 54% (n=22) in patients treated with antiplatelet medications and 75% (n=3) in anticoagulated patients. In medically managed patients without stroke recurrence, the median reported follow-up was 24 months (range 14-100 months). Seventy (72%) patients with symptomatic CW were treated with carotid revascularization (CR; Table 2 ). Fifty patients underwent primary CR for secondary stroke prevention. An additional 20 patients ultimately underwent CR after experiencing a recurrent stroke despite medical management. Of these 70 patients, 35 (50%) had CEA and 35 (50%) carotid artery stenting. No procedural complications were reported in these 70 patients. Follow-up data were reported for 42 (60%) CR patients (median duration 14 months, range 3-144 months); all CR patients remained stroke-free during this period. Medical therapy post-CR was not well described.
Symptomatic CW and Carotid Stenosis
The degree of carotid stenosis was available for 49 patients (Table 3) . The majority of patients (84%) had mild stenosis, versus 10% moderate stenosis, and 6% severe stenosis. Increased degree of stenosis correlated with higher rates of recurrent stroke, but this was not statistically significant (mild=44% versus moderate=80%; P=0.184). Three symptomatic patients with severe stenosis were reported. Of those 3 patients; 1 died 24 hours after presentation from complications of stroke, 1 underwent successful CEA, and 1 did not undergo CR. No follow-up data were available on the CW patients with severe stenosis.
Discussion
In 1968, Rainer et al 1 described a young woman with recurrent transient neurological symptoms because of CW. Since then, many cases with similar presentations have been reported in the literature, under a variety of descriptions, including CW, diaphragm, septum, shelf, and atypical focal carotid bulb FMD (Table I in the online-only Data Supplement). Unlike carotid atherosclerotic disease, the underlying mechanism of stroke in CW patients is presumably secondary to turbulent blood flow and stasis, resulting in thrombosis and embolism. 2 This hypothesis is supported by cerebral angiography demonstrating marked stasis of intravenous contrast distal to the CW in one of our patients (Figure 2 ), a finding that has also been reported elsewhere. [11] [12] [13] Furthermore, one of our patients developed visible thrombus distal to the CW that resolved after initiation of anticoagulation.
2 Consistent with this proposed pathophysiology, our study found that patients with symptomatic CW are young with few conventional stroke risk factors. Among CW patients with stroke risk factors, hypertension, hyperlipidemia, smoking, and oral contraceptive use were most common. We also found that CW was most common among patients of African descent; however, publication bias due to the 2 largest case series in our SLR (reporting a total of 43 African patients) may have had disproportionately influenced our findings. 8, 13 Similar to classic FMD, our CW cohort was predominantly women.
14 Interestingly, women made up 50% of the asymptomatic CW cohort, but 67% of the symptomatic CW cohort. Interaction between CW and stroke risk factors more commonly present in women (ie, endogenous/ exogenous estrogen or migraine aura) may be responsible for this finding. Optimal management strategies for CW are yet to be defined. Within this context, the findings from our SLR, the largest and most comprehensive collection of CW patients published to date, are especially notable. More than half of symptomatic CW patients treated with standard medical therapy (primarily antiplatelet agents) had stroke recurrence with a median time to recurrent stroke of only 12 months. In theory, antiplatelet agents may be especially ineffective in CW, because of their limited efficacy in low flow states with significant stasis. 2 However, in our SLR the risk of recurrent stroke was high even in CW patients treated with anticoagulation although the sample size was extremely small.
In direct contrast to the high stroke recurrence rates observed with medical management, no recurrent strokes occurred in patients treated with CEA or carotid artery stenting over the reported follow-up period. Carotid stenosis secondary to CW may be particularly amenable to revascularization because of relative stability of the lesion in comparison with ruptured atherosclerotic plaque. Additionally, the lack of conventional stroke and cardiovascular risk factors may contribute to the low rate of periprocedural complications with CR in comparison to known complication rates for CEA and carotid artery stenting in asymptomatic and symptomatic carotid atherosclerotic disease (3.6%-6.7%). 15 Conversely, the underlying arteriopathy itself (intimal FMD) may respond adversely to carotid artery stenting or CEA resulting in recurrence of CW at, or adjacent to, the revascularization site. Studies with diligent reporting of long-term outcomes are essential to shed further light on the benefits of CR in patients with CW.
We did not find a clear correlation between degree of stenosis and stroke recurrence-in fact, the large majority of symptomatic CW patients had only mild stenosis. Comparing recurrent stroke rates in mild and moderate stenosis to severe carotid stenosis was not possible because none of the patients with severe stenosis had reported follow-up. These findings suggest that the hemodynamic effects of CW may become clinically relevant with lesser degree of stenosis in comparison to atherosclerotic plaque. Therefore, it remains unclear whether degree of stenosis appropriately stratifies the risk of primary or recurrent stroke in CW patients, or whether individual flow hemodynamics are more relevant.
Our study has several limitations. First, the diagnosis of CW in our SLR was primarily based upon neuroimaging without histopathologic confirmation. Thus, our cohort may be a mix of both CW and non-CW patients. In clinical practice, however, surgical pathology is not available to guide prospective treatment and, like FMD, the diagnosis of CW is primarily radiographic. 16 Therefore, our findings remain generalizable to patients with the radiographic diagnosis of CW. With advances in noninvasive imaging modalities, computed tomography angiography has proven to be a reliable method of detecting CW. 2 Recently, several groups have also published magnetic resonance imaging characteristics of CW, which included homogenous isointense signal of T2-weighted sequences, slight hyperintense signal on T1-weighted sequences, mild gadolinium enhancement of the inner layer, and evidence of impaired hemodynamics. [17] [18] [19] A second limitation inherent in our SLR is the risk of publication bias. Our data may be skewed by authors who are more likely to report symptomatic CW cases and less inclined to report procedural complications of CR. In spite of those concerns, our findings were consistent across individual studies. It seems unlikely that such dramatic stroke recurrence rates with medical management and lack of any periprocedural complications or recurrent stroke with CR for CW could be a function of publication bias alone.
Finally, because we included manuscripts dating back as far as 1968, complete patient-level data were not always available. Our study, however, still represents the most comprehensive compilation of CW patients and patient-level data to date. Most importantly, in spite of the aforementioned A 49-year-old woman with carotid web (CW) and migraine aura who initially presented with acute onset aphasia and right sided weakness. A, Diffusion-weighted magnetic resonance imaging demonstrating stroke in the left caudate and putamen post-thrombectomy of an occluded left middle cerebral artery. B, Recurrent stroke 6 mo later in the left corona radiata while taking aspirin. C, Shelf-like filling defect in the left proximal internal carotid artery seen on cerebral angiogram (arrowhead), consistent with CW. On sequential alternating frames (2/3 seconds apart), the contrast injection clears the internal carotid artery, whereas marked contrast stagnation (arrow) is appreciated distal to the CW.
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limitations, our SLR provides convincing evidence that medical management of symptomatic CW (especially with antiplatelet agents) may confer a high risk of stroke recurrence. In stark contrast, the published literature suggests CR for CW patients is safe and effective. Both of these findings are critically important considerations in the management of CW. We are unable to generalize our findings in symptomatic CW to patients with asymptomatic CW because of the low sample size and lack of follow-up data. In the future, prospective registries or randomized clinical trials are needed to improve our understanding of CW, with better elucidation of high-and low-risk features with respect to medical and surgical management.
Conclusions
CW is an under-recognized entity leading to stroke in young patients without conventional stroke risk factors. We found a high stroke recurrence rate in medically managed symptomatic CW patients, whereas CR effectively prevented recurrent stroke. Our findings should be interpreted with caution because of risk of publication and reporting bias.
